Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07161583 · ClinicalTrials.gov registry record

Advanta VXT and Flixene PMCF Registry

A clinical trial of Peripheral Arterial Disease, sponsored by Atrium Medical Corporation.

Recruiting
Registry status
1,000
Enrollment target
2
Study locations

NCT07161583 is a study of Peripheral Arterial Disease that is actively recruiting participants, run by Atrium Medical Corporation. The registered enrollment target is 1,000 participants, below the 4,194-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07161583, a study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Atrium Medical Corporation.

RECRUITING
Registry status
1,000 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.

Conditions Studied

Peripheral Arterial Disease

Interventions

  • DEVICE Advanta VXT Vascular Graft
  • DEVICE Flixene Vascular Graft

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston

Brittany Region

  • CHU de Brest - Brest

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-09-25
Est. Completion 2026-10

Sponsor

Atrium Medical Corporation

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07161583

The ClinicalTrials.gov registry entry for NCT07161583 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,194-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (76% lower). The listed sponsor is Atrium Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Advanta VXT Vascular Graft is the first listed.

NCT07161583 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Brittany Region.

Frequently Asked Questions

What is clinical trial NCT07161583 about?

NCT07161583 is a clinical study titled "Advanta VXT and Flixene PMCF Registry". The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular graft...

What is the current status of trial NCT07161583?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-09-25. Estimated completion is 2026-10.

What conditions does trial NCT07161583 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT07161583?

The interventions under investigation include: Advanta VXT Vascular Graft (DEVICE), Flixene Vascular Graft (DEVICE).

Who is sponsoring clinical trial NCT07161583?

This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07161583 being conducted?

This trial has 2 study locations across Massachusetts, Brittany Region. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Arterial Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.